<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Individuals with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), such as <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) or <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) are at increased risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) over healthy individuals </plain></SENT>
<SENT sid="1" pm="."><plain>This risk is proportional to the duration and extent of disease, with a cumulative incidence as high as 30% in individuals with longstanding UC with widespread colonic involvement </plain></SENT>
<SENT sid="2" pm="."><plain>Colonic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in IBD and <z:hpo ids='HP_0002583'>colitis</z:hpo> associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (CAC) are believed to develop as a result of repeated cycles of epithelial cell injury and repair while these cells are bathed in a <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory cytokine milieu </plain></SENT>
<SENT sid="3" pm="."><plain>While spontaneous and <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> share the quality of being <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, the sequence of underlying molecular events is believed to be different </plain></SENT>
<SENT sid="4" pm="."><plain>This distinction argues the need for specific animal models of CAC </plain></SENT>
<SENT sid="5" pm="."><plain>Several mouse models currently exist for the study of CAC </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="34674">Dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> (DSS), an agent with direct toxic effects on the colonic epithelium, can be administered in drinking water to mice in multiple cycles to create a <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory state </plain></SENT>
<SENT sid="7" pm="."><plain>With sufficient duration, some of these mice will develop <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> development is hastened in this model if administered in a pro-carcinogenic setting </plain></SENT>
<SENT sid="9" pm="."><plain>These include mice with genetic mutations in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> pathways (APC, p53, Msh2), as well as mice pre-treated with <z:chebi fb="0" ids="50902">genotoxic agents</z:chebi> (azoxymethane [AOM], 1,2-dimethylhydrazine [DMH]) </plain></SENT>
<SENT sid="10" pm="."><plain>The combination of DSS with AOM as a model for <z:hpo ids='HP_0002583'>colitis</z:hpo> associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> has gained popularity for its reproducibility, potency, low price, and ease of use </plain></SENT>
<SENT sid="11" pm="."><plain>Though they have a shared mechanism, AOM has been found to be more potent and stable in solution than DMH </plain></SENT>
<SENT sid="12" pm="."><plain>While <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in other models generally requires several months, mice injected with AOM and subsequently treated with DSS develop adequate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in as little as 7-10 weeks </plain></SENT>
<SENT sid="13" pm="."><plain>Finally, AOM and DSS can be administered to mice of any genetic background (knock out, transgenic, etc.) without cross-breeding to a specific tumorigenic strain </plain></SENT>
<SENT sid="14" pm="."><plain>Here, we demonstrate a protocol for <z:mp ids='MP_0001845'>inflammation</z:mp>-driven colonic <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in mice utilizing a single injection of AOM followed by three seven-day cycles of DSS over a 10 week period </plain></SENT>
<SENT sid="15" pm="."><plain>This model induces <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with histological and molecular changes closely resembling those occurring in human CAC and provides a highly valuable model for the study of <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> and chemoprevention in this disease </plain></SENT>
</text></document>